Brief: Novartis Agrees To Acquire Excellergy, Inc.
27/03/2026 06:05
March 27 (Reuters) - Novartis AG NOVN.S: NOVARTIS AGREES TO ACQUIRE EXCELLERGY, INC., BUILDING ON ALLERGY LEADERSHIP WITH NEXT-GENERATION ANTI-IGE INNOVATION NOVARTIS AG - TO PAY UP TO $2 BILLION TO BUY EXCELLERGY NOVARTIS AG - NOVARTIS WILL PAY UP TO USD 2 BILLION IN UPFRONT AND MILESTONE PAYMENTS TO ACQUIRE EXCELLERGY NOVARTIS AG - TRANSACTION IS EXPECTED TO CLOSE IN H2 2026 Source text: ID:nGNEb9mj8R Further company coverage: NOVN.S (Gdansk Newsroom) (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))
Recent news on Novartis AG
See all newsBrief: Novartis Remind Data At Eaaci Show Rhapsido Potential As First Targeted Therapy For Chronic Inducible Urticaria (Cindu)
Swiss stocks - Factors to watch on June 12
Swiss pharma hub Basel frets over population cap threat
Novartis says rare muscle disease drug shows promise in early trial
Live Markets: Europe at half-time: countdown to the ECB's 'insurance hike'